Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
-0.27%
617.51
-1.70
-0.27%
—619.21618.96618.96615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+0.88%
535.53
+4.67
+0.88%
—530.86530.03536.69526.25——
SX8P
Technology
SX8P
Technology
SX8P
-0.34%
927.43
-3.19
-0.34%
—930.62924.86935.91921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.89%
447.44
-8.61
-1.89%
—456.05452.80452.80446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.76%
1,082.31
-8.32
-0.76%
—1,090.631,086.801,086.801,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+1.81%
545.01
+9.67
+1.81%
—535.34536.16545.74536.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.68%
884.20
-6.03
-0.68%
—890.23887.34889.41883.68——
SXKP
Communications
SXKP
Communications
SXKP
+0.56%
314.52
+1.74
+0.56%
—312.78311.95316.04310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
-0.70%
1,087.98
-7.62
-0.70%
—1,095.601,090.801,091.751,082.31——
SXPP
Materials
SXPP
Materials
SXPP
-0.78%
811.66
-6.41
-0.78%
—818.07813.89816.05804.46——
RLMD:NASDAQ
Relmada Therapeutics Inc
$6.90
-7.01%
(-0.52) 1D
$6.90
0.00% (0.00)
Pre-market
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLMD...
Open
$7.19
High
$7.33
Low
$6.77
Mkt. cap
723.74M
Avg. vol.
1.18M
Volume
1.67K
52-wk high
$8.00
52-wk low
$0.40
EPS
-$1.15
Beta
0.43
Shares outstanding
104.89M
No. of employees
17
News stories
From sources across the web
About Relmada Therapeutics Inc
CEO-
Employees17
Founded2004
HeadquartersCoral Gables, Florida, United States
SectorPharmaceutical industry
Websiterelmada.com
Last report
Nov 10, 2022
Fiscal Period
Q3 2022
EPS / Est. (USD)
-$1.31 / -$1.47
+10.88%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2022 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.82M
4.04M
5.17M
8.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.40M
6.29M
12.26M
11.37M
Operating expense
10.22M
10.33M
17.43M
19.46M
Total operating expenses
10.22M
10.33M
17.43M
19.46M
Operating income
-10.22M
-10.33M
-17.43M
-19.46M
Other non operating income
-
-
-
-
EBT including unusual items
-9.87M
-10.09M
-19.87M
-19.05M
EBT excluding unusual items
-9.90M
-10.08M
-17.05M
-18.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.87M
-10.09M
-19.87M
-19.05M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
321.46K
247.01K
387.23K
959.76K
Interest expense
-
-
-
-
Net interest expenses
321.46K
247.01K
387.23K
959.76K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer